Literature DB >> 22034641

Mutations in multiple PKD genes may explain early and severe polycystic kidney disease.

Carsten Bergmann1, Jennifer von Bothmer, Nadina Ortiz Brüchle, Andreas Venghaus, Valeska Frank, Henry Fehrenbach, Tobias Hampel, Lars Pape, Annegret Buske, Jon Jonsson, Nanette Sarioglu, Antónia Santos, Jose Carlos Ferreira, Jan U Becker, Reinhold Cremer, Julia Hoefele, Marcus R Benz, Lutz T Weber, Reinhard Buettner, Klaus Zerres.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is typically a late-onset disease caused by mutations in PKD1 or PKD2, but about 2% of patients with ADPKD show an early and severe phenotype that can be clinically indistinguishable from autosomal recessive polycystic kidney disease (ARPKD). The high recurrence risk in pedigrees with early and severe PKD strongly suggests a common familial modifying background, but the mechanisms underlying the extensive phenotypic variability observed among affected family members remain unknown. Here, we describe severely affected patients with PKD who carry, in addition to their expected familial germ-line defect, additional mutations in PKD genes, including HNF-1β, which likely aggravate the phenotype. Our findings are consistent with a common pathogenesis and dosage theory for PKD and may propose a general concept for the modification of disease expression in other so-called monogenic disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22034641      PMCID: PMC3279997          DOI: 10.1681/ASN.2010101080

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  27 in total

1.  Renal phenotypes related to hepatocyte nuclear factor-1beta (TCF2) mutations in a pediatric cohort.

Authors:  Tim Ulinski; Sandra Lescure; Sandrine Beaufils; Vincent Guigonis; Stéphane Decramer; Denis Morin; Séverine Clauin; Georges Deschênes; François Bouissou; Albert Bensman; Christine Bellanné-Chantelot
Journal:  J Am Soc Nephrol       Date:  2005-12-21       Impact factor: 10.121

Review 2.  Polycystic kidney disease--a truly pediatric problem.

Authors:  M R Ogborn
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

3.  Disruption of a ciliary B9 protein complex causes Meckel syndrome.

Authors:  William E Dowdle; Jon F Robinson; Andreas Kneist; M Salomé Sirerol-Piquer; Suzanna G M Frints; Kevin C Corbit; Norann A Zaghloul; Norran A Zaghloul; Gesina van Lijnschoten; Leon Mulders; Dideke E Verver; Klaus Zerres; Randall R Reed; Tania Attié-Bitach; Colin A Johnson; José Manuel García-Verdugo; Nicholas Katsanis; Carsten Bergmann; Jeremy F Reiter
Journal:  Am J Hum Genet       Date:  2011-07-15       Impact factor: 11.025

4.  Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5.

Authors:  Christine Bellanné-Chantelot; Séverine Clauin; Dominique Chauveau; Philippe Collin; Michèle Daumont; Claire Douillard; Danièle Dubois-Laforgue; Laurent Dusselier; Jean-François Gautier; Michel Jadoul; Marie Laloi-Michelin; Laetitia Jacquesson; Etienne Larger; Jacques Louis; Marc Nicolino; Jean-François Subra; Jean-Marie Wilhem; Jacques Young; Gilberto Velho; José Timsit
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

5.  Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys.

Authors:  Stéphane Decramer; Olivier Parant; Sandrine Beaufils; Séverine Clauin; Cécile Guillou; Sylvie Kessler; Jacqueline Aziza; Flavio Bandin; Joost P Schanstra; Christine Bellanné-Chantelot
Journal:  J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 10.121

Review 6.  Algorithm for efficient PKHD1 mutation screening in autosomal recessive polycystic kidney disease (ARPKD).

Authors:  Carsten Bergmann; Fabian Küpper; Christian Dornia; Frank Schneider; Jan Senderek; Klaus Zerres
Journal:  Hum Mutat       Date:  2005-03       Impact factor: 4.878

7.  Childhood onset autosomal dominant polycystic kidney disease in sibs: clinical picture and recurrence risk. German Working Group on Paediatric Nephrology (Arbeitsgemeinschaft für Pädiatrische Nephrologie.

Authors:  K Zerres; S Rudnik-Schöneborn; F Deget
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

8.  Mutation of hepatocyte nuclear factor-1beta inhibits Pkhd1 gene expression and produces renal cysts in mice.

Authors:  Thomas Hiesberger; Yun Bai; Xinli Shao; Brian T McNally; Angus M Sinclair; Xin Tian; Stefan Somlo; Peter Igarashi
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

9.  A transcriptional network in polycystic kidney disease.

Authors:  Lionel Gresh; Evelyne Fischer; Andreas Reimann; Myriam Tanguy; Serge Garbay; Xinli Shao; Thomas Hiesberger; Laurence Fiette; Peter Igarashi; Moshe Yaniv; Marco Pontoglio
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

10.  Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1).

Authors:  Carsten Bergmann; Jan Senderek; Beate Sedlacek; Ioannis Pegiazoglou; Patricia Puglia; Thomas Eggermann; Sabine Rudnik-Schöneborn; Laszlo Furu; Luiz F Onuchic; Monica De Baca; Gregory G Germino; Lisa Guay-Woodford; Stefan Somlo; Markus Moser; Reinhard Büttner; Klaus Zerres
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  90 in total

1.  The Polycystin-1, Lipoxygenase, and α-Toxin Domain Regulates Polycystin-1 Trafficking.

Authors:  Yaoxian Xu; Andrew J Streets; Andrea M Hounslow; Uyen Tran; Frederic Jean-Alphonse; Andrew J Needham; Jean-Pierre Vilardaga; Oliver Wessely; Michael P Williamson; Albert C M Ong
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

Review 2.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

3.  Type of PKD1 mutation influences renal outcome in ADPKD.

Authors:  Emilie Cornec-Le Gall; Marie-Pierre Audrézet; Jian-Min Chen; Maryvonne Hourmant; Marie-Pascale Morin; Régine Perrichot; Christophe Charasse; Bassem Whebe; Eric Renaudineau; Philippe Jousset; Marie-Paule Guillodo; Anne Grall-Jezequel; Philippe Saliou; Claude Férec; Yannick Le Meur
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

4.  Diverse phenotypic expression of NPHP4 mutations in four siblings.

Authors:  Sevcan A Bakkaloğlu; Yaşar Kandur; Tuğba Bedir-Demirdağ; İpek Işık-Gönül; Friedhelm Hildebrandt
Journal:  Turk J Pediatr       Date:  2014 Jul-Aug       Impact factor: 0.552

Review 5.  Whole exome sequencing: a state-of-the-art approach for defining (and exploring!) genetic landscapes in pediatric nephrology.

Authors:  Ashima Gulati; Stefan Somlo
Journal:  Pediatr Nephrol       Date:  2017-06-29       Impact factor: 3.714

Review 6.  Variable Cyst Development in Autosomal Dominant Polycystic Kidney Disease: The Biologic Context.

Authors:  Wouter N Leonhard; Hester Happe; Dorien J M Peters
Journal:  J Am Soc Nephrol       Date:  2016-08-04       Impact factor: 10.121

Review 7.  Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Vicente E Torres
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

8.  Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.

Authors:  Matthew B Lanktree; Amirreza Haghighi; Elsa Guiard; Ioan-Andrei Iliuta; Xuewen Song; Peter C Harris; Andrew D Paterson; York Pei
Journal:  J Am Soc Nephrol       Date:  2018-08-22       Impact factor: 10.121

9.  The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations.

Authors:  Emilie Cornec-Le Gall; Fouad T Chebib; Charles D Madsen; Sarah R Senum; Christina M Heyer; Brendan C Lanpher; Marc C Patterson; Robert C Albright; Alan S Yu; Vicente E Torres; Peter C Harris
Journal:  Am J Kidney Dis       Date:  2018-02-01       Impact factor: 8.860

10.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.